Hugon J - Search Results

1

How many patients are eligible for disease-modifying treatment in Alzheimer's disease? A French national observational study over 5 years.

Epelbaum S, Paquet C, Hugon J, Dumurgier J, Wallon D, Hannequin D, Jonveaux T, Besozzi A, Pouponneau S, Hommet C, Blanc F, Berly L, Julian A, Paccalin M, Pasquier F, Bellet J, Boutoleau-Bretonniere C, Charriau T, Rouaud O, Madec O, Mouton A, David R, Bekadar S, Fabre R, Liegey E, Deberdt W, Robert P, Dubois B. Epelbaum S, et al. Among authors: hugon j. BMJ Open. 2019 Jun 24;9(6):e029663. doi: 10.1136/bmjopen-2019-029663. BMJ Open. 2019. PMID: 31239309 Free PMC article.

2

mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease.

Lafay-Chebassier C, Paccalin M, Page G, Barc-Pain S, Perault-Pochat MC, Gil R, Pradier L, Hugon J. Lafay-Chebassier C, et al. Among authors: hugon j. J Neurochem. 2005 Jul;94(1):215-25. doi: 10.1111/j.1471-4159.2005.03187.x. J Neurochem. 2005. PMID: 15953364 Free article.

3

The relation between p70S6k expression in lymphocytes and the decline of cognitive test scores in patients with Alzheimer disease.

Paccalin M, Pain-Barc S, Pluchon C, Paul C, Bazin H, Gil R, Hugon J. Paccalin M, et al. Among authors: hugon j. Arch Intern Med. 2005 Nov 14;165(20):2428-9. doi: 10.1001/archinte.165.20.2428. Arch Intern Med. 2005. PMID: 16287775 Clinical Trial. No abstract available.

4

Activated mTOR and PKR kinases in lymphocytes correlate with memory and cognitive decline in Alzheimer's disease.

Paccalin M, Pain-Barc S, Pluchon C, Paul C, Besson MN, Carret-Rebillat AS, Rioux-Bilan A, Gil R, Hugon J. Paccalin M, et al. Among authors: hugon j. Dement Geriatr Cogn Disord. 2006;22(4):320-6. doi: 10.1159/000095562. Epub 2006 Sep 4. Dement Geriatr Cogn Disord. 2006. PMID: 16954686

5

Peripheral p70S6k levels and emotional memory in patients with Alzheimer's disease.

Paccalin M, Al Khidir F, Barc SP, Pluchon C, Perrault-Pochat MC, Gil R, Hugon J. Paccalin M, et al. Among authors: hugon j. Neurosci Lett. 2006 Dec 27;410(3):162-4. doi: 10.1016/j.neulet.2006.07.053. Epub 2006 Nov 13. Neurosci Lett. 2006. PMID: 17101223

6

Could non coding RNA be involved in Alzheimer's disease?

Paquet C, Hugon J. Paquet C, et al. Among authors: hugon j. Med Hypotheses. 2007;69(2):464-5. doi: 10.1016/j.mehy.2006.12.037. Epub 2007 Feb 20. Med Hypotheses. 2007. PMID: 17317029 No abstract available.

7

Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease.

Paquet C, Boissonnot M, Roger F, Dighiero P, Gil R, Hugon J. Paquet C, et al. Among authors: hugon j. Neurosci Lett. 2007 Jun 13;420(2):97-9. doi: 10.1016/j.neulet.2007.02.090. Epub 2007 Mar 19. Neurosci Lett. 2007. PMID: 17543991

8

Dissociation of Akt/PKB and ribosomal S6 kinase signaling markers in a transgenic mouse model of Alzheimer's disease.

Damjanac M, Rioux Bilan A, Paccalin M, Pontcharraud R, Fauconneau B, Hugon J, Page G. Damjanac M, et al. Among authors: hugon j. Neurobiol Dis. 2008 Feb;29(2):354-67. doi: 10.1016/j.nbd.2007.09.008. Epub 2007 Oct 11. Neurobiol Dis. 2008. PMID: 18023354

9

[Molecular and therapeutic approaches of the Alzheimer's disease].

Hugon J, Paquet C. Hugon J, et al. Morphologie. 2007 Dec;91(295):221-5. doi: 10.1016/j.morpho.2007.10.012. Epub 2007 Nov 28. Morphologie. 2007. PMID: 18054263 French.

10

Targeting miRNAs in Alzheimer's disease.

Hugon J, Paquet C. Hugon J, et al. Expert Rev Neurother. 2008 Nov;8(11):1615-6. doi: 10.1586/14737175.8.11.1615. Expert Rev Neurother. 2008. PMID: 18986230 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

476 results

Search Page

Filters